BioCorRx (BICX) Net Income Attributable to Noncontrolling Interests (2017 - 2026)
BioCorRx (BICX) posted Income from Non-Controlling Interests of -$28,665 for Q1 2026, compared with -$10,357 a year earlier.
Powered by 
Analysis
BioCorRx (BICX) Net Income Attributable to Noncontrolling Interests (2017 - 2026) Analysis & Trends
For the trailing twelve months through Mar 31, 2026, Income from Non-Controlling Interests at BioCorRx was -$395,355; for FY2025, it came in at -$68,617.
- In prior years, BioCorRx's Income from Non-Controlling Interests was -$105,978 in FY2024 and -$5.28 million in FY2021.
- Quarterly Income from Non-Controlling Interests has run from a low of -$1.36 million in Q3 2021 to a high of $886,539 in Q4 2025 over five years.
- According to Business Quant data, Income from Non-Controlling Interests for the three prior quarters was $886,539 (Q4 2025), -$1.11 million (Q3 2025) and -$143,858 (Q2 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCI Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | - |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | - |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 2.00 Mn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 2.00 Mn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | -1.00 Mn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | - |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | - |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 10.00 Mn |
| 10 | BioCorRx | 830.00 | -906,148.00 | -56,997.00 | -964,774.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -964,774.00 |
| Mar 31, 2026 | -28,665.00 |
| Dec 31, 2025 | 886,539.00 |
| Sep 30, 2025 | -1.11 Mn |
| Jun 30, 2025 | -143,858.00 |
| Mar 31, 2025 | -10,357.00 |
| Dec 31, 2024 | -148,938.00 |
| Sep 30, 2024 | 25,623.00 |
| Jun 30, 2024 | -16,650.00 |
| Mar 31, 2024 | -1.24 Mn |
| Dec 31, 2023 | -968,540.00 |
| Sep 30, 2023 | -866,280.00 |
| Jun 30, 2023 | -922,441.00 |
| Mar 31, 2023 | -922,441.00 |
| Dec 31, 2022 | -1.16 Mn |
| Sep 30, 2022 | -949,118.00 |
| Jun 30, 2022 | -1.32 Mn |
| Mar 31, 2022 | -944,440.00 |
| Dec 31, 2021 | -1.27 Mn |
| Sep 30, 2021 | -1.36 Mn |
API Access
BioCorRx Net Income Attributable to Noncontrolling Interests API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=income-from-non-controlling-interests&ticker=BICX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "income-from-non-controlling-interests", "ticker": "BICX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=income-from-non-controlling-interests&ticker=BICX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();